Patent · US Active

Antibodies directed against prothrombin fragment F1+2, the preparation and use thereof

US7795403B2 · kind B2 · utility

1Cited by

2References

16Claims

0Family size

Assignee

Siemens Healthcare Diagnostics Products GmbH · DE

Inventors

Stefan Teigelkamp · Niederwalgern, DE
Konrad Braun · Allendorf (Lumda), DE

Key dates

Filing date	Nov 19, 2004
Grant date	Sep 14, 2010
Priority date	—
Expiry date	Oct 14, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y304/21005
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention relates to antibodies directed against F1+2, to the preparation and use thereof, especially in therapy and diagnosis. The antibodies bind to an epitope on the N-terminal half of the F2 fragment of prothrombin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.